Carnosine And Anti-Ageing
Quick Read Carnosine is a small molecule your muscles naturally produce that declines with age. Research suggests it fights three
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
What if one of the most powerful things a woman could do for her cervical health wasn’t a medical procedure — but something as quietly fundamental as maintaining adequate levels of a single B vitamin? Most of us know folate as the pregnancy nutrient, the one midwives mention in the first trimester. But a growing body of research suggests its role in women’s health extends well beyond those early weeks of pregnancy — and into cervical tissue health across a lifetime. Here’s what decades of science have uncovered, what’s still uncertain, and what it might mean for you.
To understand why folate matters for your cervix, you first need to understand what folate actually does inside your cells.
Folate (vitamin B9) is essential for what scientists call one-carbon metabolism — a set of chemical reactions that control two critical processes: DNA synthesis and DNA methylation. Think of DNA methylation as your genome’s annotation system. It places chemical “tags” on your DNA that tell genes to switch on or off. When this system works well, healthy cells stay healthy and abnormal cells are flagged for destruction. When it breaks down — partly through folate deficiency — that careful regulation can go awry [8].
This matters for cervical health because the cervix is one of the most rapidly dividing tissues in the body, making it particularly sensitive to anything that disrupts DNA repair and methylation. Add in the human papillomavirus (HPV) — which is present in virtually all cases of cervical cancer — and the picture gets more complex. HPV doesn’t cause cancer on its own; most women who have HPV clear it naturally. What folate appears to do is influence how well your immune system and cellular repair mechanisms handle that exposure [10][11].
There’s also a genetic dimension that makes this more nuanced than it first appears: certain common genetic variants — particularly in an enzyme called methylenetetrahydrofolate reductase (MTHFR) — affect how efficiently your body processes folate. Women with these variants may face an amplified risk when their folate intake is also low [4][7].
*This blog post was compiled by VitacuityAI, which analysed 1.7 million research papers and selected the most relevant studies on this topic.*
Evidence grade: Promising — multiple observational studies and a meta-analysis, but largely cross-sectional and observational rather than interventional trial data.
The most comprehensive overview of this field comes from a 2025 meta-analysis published in the *European Journal of Cancer Prevention* [1]. Researchers pooled data across multiple studies to examine whether folate levels correlated with risk of cervical intraepithelial neoplasia (CIN) — the medical term for precancerous changes in cervical cells — and cervical cancer itself.
The results were striking. Women in the higher three quartiles of serum folate (meaning those with adequate to good folate levels) had 58% lower odds of CIN compared to women in the lowest quartile (OR = 0.42, 95% CI: 0.28–0.62). When the researchers drilled down into severity, higher serum folate was associated with:
– 48% lower odds of CIN grade 1 (OR = 0.52, 95% CI: 0.29–0.93) – 67% lower odds of CIN grades 2 or 3 — the more serious precancerous changes (OR = 0.33, 95% CI: 0.19–0.58) – 47% lower odds of cervical cancer (OR = 0.53, 95% CI: 0.36–0.79)
In other words, the protective association appeared to strengthen with lesion severity — which is exactly what you’d hope to see if the relationship were genuinely biological rather than coincidental [1].
One important nuance: the meta-analysis found that serum folate (the folate circulating in your blood) drove these associations, while erythrocyte folate (stored in red blood cells) showed a weaker, non-significant association with CIN risk in the same analysis (OR = 0.69, 95% CI: 0.43–1.12) [1]. This distinction matters, and we’ll return to it.
Evidence grade: Promising — large cross-sectional study, but causality not established.
Here’s an angle that many people haven’t considered: could folate affect not just what happens *after* HPV infection, but the infection itself?
A 2024 study published in *The Journal of Nutrition* used data from the National Health and Nutrition Examination Survey (NHANES) — a large, nationally representative US sample of 11,801 women aged 18–59 [10]. The researchers looked at whether serum folate levels were associated with testing positive for high-risk HPV strains (the types linked to cervical cancer).
The findings were clear and dose-dependent. Women in the lowest quintile of serum folate (below 21.3 nmol/L) were 40–52% more likely to test positive for high-risk HPV than women in the highest quintile — even after adjusting for lifestyle factors and sexual risk factors for HPV. The trend was statistically significant across all quintiles (P < 0.0001) [10].
This doesn’t prove that low folate *causes* HPV infection — the study design can’t establish that. But it raises an intriguing possibility: adequate folate may support immune function in ways that help the body resist or clear HPV more effectively. That would make the folate–cervical health story even more important than the DNA repair angle alone suggests.
Evidence grade: Promising — consistent across multiple independent studies, though sample sizes are moderate.
Not all women process folate equally. A common genetic variant in the MTHFR gene — specifically the C677T polymorphism — reduces the enzyme’s efficiency, meaning some women are effectively folate-deficient at the cellular level even when their dietary intake looks fine.
A 2001 multiethnic case-control study from Hawaii, published in *Cancer Research* [4], examined 150 women with cervical squamous intraepithelial lesions (SILs) and 179 women with normal smears. The results painted a remarkably clear picture:
– Women with one copy of the variant T allele (heterozygous CT) had twice the risk of cervical SILs (OR = 2.0, 95% CI: 1.1–3.7) – Women with two copies (homozygous TT) had almost three times the risk (OR = 2.9, 95% CI: 1.0–8.8) – Women with the variant T allele AND low folate intake had five times the risk (OR = 5.0, 95% CI: 2.0–12.2) compared to women with the normal CC genotype and adequate folate
That five-fold risk figure is important. It suggests that genetic vulnerability and nutritional deficiency interact — neither alone tells the full story [4].
A separate 2013 Brazilian case-control study of 950 women published in the *American Journal of Clinical Nutrition* [7] confirmed and expanded this. Using a “genetic risk score” that summed multiple risk alleles across several folate-pathway genes, researchers found that women with four or more risk alleles *and* low folate intake had a 67% higher risk of CIN2+ compared to women with fewer risk alleles and adequate folate. The effect was amplified further when serum vitamin B6 was also low [7].
Evidence grade: Promising — well-designed nested case-control study from an RCT cohort, but small numbers in some strata.
One of the most clinically meaningful studies in this area was published in *European Journal of Nutrition* in 2024 [11]. Researchers conducted a nested case-control study within the ASCUS-COL trial — a randomised clinical trial — examining 155 women with confirmed CIN2+ lesions and 155 matched controls.
They looked at the interaction between serum folate levels and HPV genome methylation (a marker of how actively HPV is behaving). The headline finding:
– Folate deficiency alone was associated with elevated CIN3+ risk – High HPV methylation alone was associated with elevated CIN3+ risk – But women with BOTH folate deficiency AND high methylation levels had nearly nine times the risk of CIN3+ (OR = 8.9, 95% CI: 3.4–24.9) compared to women with normal folate and high methylation (OR = 1.4, 95% CI: 0.4–4.6) [11]
This suggests folate deficiency and abnormal HPV methylation are not just additive risks — they may amplify each other dramatically. Folate appears to play a regulatory role in controlling how HPV behaves in infected cells, not just in maintaining healthy cervical tissue generally.
Evidence grade: Promising — case-control data with dose-response patterns, but dietary recall limitations apply.
A 2003 case-control study published in *Cancer Causes and Control* [3] recruited 214 women with biopsy-confirmed cervical lesions and 271 controls from clinics in Hawaii. Participants completed detailed dietary surveys covering over 250 food items plus supplement use, and all were tested for HPV.
The findings for folate — and its B vitamin companions — were compelling. Women with the highest total folate intake (from food and supplements combined) had 50–90% lower odds of both low-grade and high-grade SIL compared to women with the lowest intake. Crucially, the association was dose-responsive: risk reduced consistently as intake increased, which is one of the markers scientists look for when assessing whether a nutritional association might be genuinely protective [3].
Similar inverse associations were found for riboflavin, thiamin, and vitamin B12 — all nutrients that work alongside folate in one-carbon metabolism. Breads, bran cereal, and fruit juice emerged as particularly protective food sources. Notably, the protective effect of adequate nutrient intake appeared strongest among women who also drank alcohol or smoked — two factors that are known to deplete B vitamin levels [3].
Evidence grade: Promising — large prospective cohort with longitudinal follow-up, though from a single population.
While most folate research has measured serum levels (the folate circulating in blood at any given time), a 2022 study published in *The Journal of Nutrition* [12] used data from the Shanxi CIN cohort of 2,304 Chinese women to examine red blood cell (RBC) folate — a marker of longer-term folate status — with particularly interesting results.
RBC folate showed a strong inverse association with CIN at all grades. Women in the lowest quartile of RBC folate had more than double the odds of CIN compared to the highest quartile (OR = 2.28, 95% CI: 1.77–2.93, P for trend < 0.001). What made this study particularly valuable was its longitudinal component: over a median follow-up of 21 months, low RBC folate was associated with nearly four times the risk of CIN1 progressing to CIN2 (OR = 3.86, 95% CI: 1.01–14.76) [12].
This is important because it’s not just about initial risk — it’s about disease progression. The finding that folate status may influence whether early-stage abnormalities advance to more serious lesions has real clinical implications.
A separate smaller Chinese study published in the *Journal of Obstetrics and Gynaecology Research* (2022) [14] found that erythrocyte folate levels differed significantly between women with normal cytology, CIN3, and cervical cancer (p = 0.03), while serum folate levels did not differ significantly between groups. This mirrors the Shanxi cohort findings and suggests that the *stored* form of folate — measured in red blood cells — may be a more sensitive marker of long-term cervical health risk than a single serum measurement.
Evidence grade: Promising — large multiethnic case-control study, but blood samples collected post-treatment in some cases.
A 2002 study published in the *Journal of Nutrition* [8] examined 183 women with invasive cervical cancer and 540 controls across five US sites. Rather than finding a strong direct relationship between folate levels and cervical cancer risk (which, interestingly, was only moderate and non-significant in this particular study), the researchers found something potentially more informative: elevated homocysteine was significantly and strongly associated with cervical cancer risk.
Women in the upper three quartiles of circulating homocysteine (above 6.31 µmol/L) had 2.4 to 3.2 times the risk of invasive cervical cancer (P for trend = 0.01), independent of HPV-16 status [8].
Why does this matter for the folate story? Homocysteine is a metabolic byproduct that accumulates when folate (and B12, and B6) are insufficient to process it efficiently. High homocysteine is essentially a downstream signal that the one-carbon metabolism system — the same system folate powers — is struggling. The researchers suggested that homocysteine may be a more accurate integrative marker of tissue-level folate insufficiency than a single serum measurement. It’s a reminder that the pathway matters as much as any single nutrient within it [8].
Honesty matters here, because the research — while genuinely interesting — has real limitations that are worth understanding.
Most of the evidence is observational. The vast majority of studies reviewed here are case-control or cross-sectional designs. These can tell us that low folate is *associated* with higher CIN risk, but they can’t definitively prove that supplementing folate *prevents* cervical abnormalities. Randomised controlled trials where women are given folate supplements and followed prospectively for cervical outcomes are largely absent from this literature [1][5].
The serum vs. RBC folate question is unresolved. The 2025 meta-analysis found serum folate drove the associations, while erythrocyte folate showed weaker results [1]. But individual studies — particularly from Chinese populations — found the opposite: RBC folate was the stronger predictor [12][14]. This discrepancy may reflect differences in populations, measurement methods, or the fact that different biomarkers capture different aspects of folate biology. We don’t yet know which measurement is most clinically meaningful.
The MTHFR findings are complex — and sometimes contradictory. The 2001 Hawaii study found that the MTHFR T variant *increased* cervical cancer risk [4], while a 2005 study in women adequately exposed to folic acid through food fortification found the variant was actually associated with *lower* CIN2/3 risk (OR = 0.43) [9]. The likely explanation is that the variant’s effect depends on overall folate availability in the population — when folate is adequate (as in fortified food environments), the variant’s impact changes. This is a genuinely complex area.
High cellular folate with genetic variants may not always be straightforwardly protective. One 2022 Brazilian study [13] found that high levels of *cellular* (intracellular) folate combined with multiple genetic polymorphisms was actually associated with increased risk of high-grade lesions — though confidence intervals were wide and sample sizes small. The relationship between different forms of folate measurement and genetic background is not simple.
The HPV clearance mechanism is not established. While the NHANES data [10] suggests higher folate is associated with lower high-risk HPV prevalence, this was a cross-sectional snapshot — not a prospective study of whether folate supplementation improves HPV clearance rates.
Most studies are in women with established lesions or HPV infection. We have much less data on whether maintaining adequate folate from a young age influences lifetime cervical cancer risk in the general population.
Here’s what a sensible, informed person would take from all of this.
The evidence that adequate folate is associated with lower risk of cervical abnormalities — from early dysplasia through to invasive cancer — is consistent enough across multiple populations, study designs, and decades of research to take seriously. The dose-response patterns are there. The biological mechanism (DNA methylation, one-carbon metabolism, immune function) is plausible and well-characterised. The associations with HPV persistence and disease progression are genuinely concerning if you’re folate-deficient. This isn’t a miracle cure story — it’s a genuine nutritional signal worth acting on.
Practically, here’s what to do:
1. Cover your folate basics. Folate is water-soluble, so excess is excreted in urine — supplementation at normal doses is safe and the surplus simply passes through. Deficiency is far more common in the UK than excess. A daily B complex or dedicated folate supplement is a low-cost, low-risk intervention with a plausible benefit for cervical health alongside many other well-established benefits. Don’t wait for testing — just supplement.
2. Eat the folate-rich foods. The diet studies [3] found that bread, bran cereal, and fruit juice were among the most protective food sources. Dark leafy greens, legumes, and fortified foods all contribute. Folate from food is absorbed well and contributes meaningfully alongside a supplement.
3. Don’t drink heavily if you can help it. The 2003 Hawaiian study [3] found that the protective effect of good B vitamin status was most pronounced among drinkers — meaning alcohol’s depletion of B vitamins likely amplifies cervical risk. If you drink regularly, keeping your B vitamins topped up is even more important.
4. Think about your full B vitamin picture. Folate doesn’t work in isolation — it works with B12, B6, and riboflavin in the one-carbon pathway. Multiple studies [3][7][8] found that B12 and B6 showed similar protective associations. A B complex that covers all of them is more logical than folate alone.
5. If you know you have MTHFR variants, consider methylfolate. The genetic data [4][7] suggests women with MTHFR variants are at amplified risk when folate status is low. If you’ve been tested and carry the C677T polymorphism, look for supplements containing methylfolate (5-MTHF) — the active form that bypasses the enzymatic step that MTHFR variants impair.
6. Keep up with cervical screening. None of this replaces smear tests and HPV vaccination. Folate is one piece of a complex picture — it’s not a substitute for regular screening, and no supplement should ever be positioned as one.
The bottom line: folate deficiency is common, testable, correctable, and — based on the weight of evidence here — potentially consequential for cervical health. A daily B complex is one of the cheapest, safest things you can do. The risk of doing nothing is almost certainly greater than the risk of supplementing.
[1] Association between folate level and cervical intraepithelial neoplasia risk: a systematic review and meta-analysis (2025). DOI: 10.1097/CEJ.0000000000000908 | https://pubmed.ncbi.nlm.nih.gov/39229939/
[2] Relationship between serum folate and CIN1 prognosis and its interaction with HR-HPV infection (2021). DOI: 10.3760/cma.j.cn112152-20200812-00732 | https://pubmed.ncbi.nlm.nih.gov/34407593/
[3] Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12 (2003). DOI: 10.1023/b:caco.0000003841.54413.98 | https://pubmed.ncbi.nlm.nih.gov/14682443/
[4] Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia (2001). https://pubmed.ncbi.nlm.nih.gov/11751445/
[5] The effects of dietary supplements in patients with cervical cancer: a comprehensive systematic review (2023). DOI: 10.1016/j.eurox.2023.100217 | https://pubmed.ncbi.nlm.nih.gov/37575366/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412901/
[6] Association of serum folate and vitamin B12 with pre-neoplastic cervical lesions (2020). DOI: 10.1016/j.clnesp.2020.04.007 | https://pubmed.ncbi.nlm.nih.gov/32690162/
[7] Polymorphisms in genes involved in folate metabolism modify the association of dietary and circulating folate and vitamin B-6 with cervical neoplasia (2013). https://pubmed.ncbi.nlm.nih.gov/24089416/
[8] Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk (2002). DOI: 10.1093/jn/132.8.2345S | https://pubmed.ncbi.nlm.nih.gov/12163690/
[9] Women with polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MS) are less likely to have cervical intraepithelial neoplasia (CIN) 2 or 3 (2005). DOI: 10.1002/ijc.20695 | https://pubmed.ncbi.nlm.nih.gov/15514969/
[10] Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women (2024). DOI: 10.1016/j.tjnut.2023.12.040 | https://pubmed.ncbi.nlm.nih.gov/38158185/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900188/
[11] Folate deficiency modifies the risk of CIN3+ associated with DNA methylation levels: a nested case-control study from the ASCUS-COL trial (2024). DOI: 10.1007/s00394-023-03289-4 | https://pubmed.ncbi.nlm.nih.gov/38129362/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10899296/
[12] Associations of RBC and Serum Folate Concentrations with Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Genotypes in Female Chinese Adults (2022). DOI: 10.1093/jn/nxab396 | https://pubmed.ncbi.nlm.nih.gov/35051275/
[13] Levels of Folate and Vitamin B12, and Genetic Polymorphisms Involved in One-Carbon Metabolism May Increase the Risk of Cervical Cytological Abnormalities (2022). DOI: 10.1080/01635581.2021.2022723 | https://pubmed.ncbi.nlm.nih.gov/34963390/
[14] Low erythrocyte folate levels and increased risk of invasive cervical cancer in Chinese women (2022). DOI: 10.1111/jog.15411 | https://pubmed.ncbi.nlm.nih.gov/36054461/
[15] The effect of red blood cell folate on the prognosis of high-risk human papillomavirus infection: a community-based cohort study (2021). DOI: 10.3760/cma.j.cn112338-20210408-00291 | https://pubmed.ncbi.nlm.nih.gov/34954983/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Carnosine is a small molecule your muscles naturally produce that declines with age. Research suggests it fights three
Quick Read CoQ10 is a molecule found in your cells’ power stations (mitochondria) that helps convert food into energy your
